Skip to main content
. 2022 Mar 29;54:2032. doi: 10.2340/jrm.v54.2032

Table I.

Characteristics of included studies

Author (country) Year Participants n (M/F) Groups (n) Mean age (SD) years Vibration parameters Duration Outcomes Key findings
Lai et al
(China) (25) 2021
Patients diagnosed with KOA
81 (11/70)
G1 (27): WBV+SE
63.52 (4.98)
G2 (27): SE
64.81 (4.04)
G3 (27): HE
63.67 (4.84)
f (Hz): 20 A (mm): 2 a (g): NR 3 (exposed time: 18–58.5 min) sessions/week
×8 weeks
Physical function TUG, 6MWT, TDPM
Knee strength ISK
G1 vs G2,
sign increase in knee extensor ISK
Aggarwal et al
(India) (23) 2020
Patients diagnosed with KOA
30 (9/21)
G1 (15): WBV+SE
M 59 (5.68) F 57.5 (7.05) G2 (15): SE
M 62 (5.88) F 61 (0)
f (Hz): 25 A (mm): NR a (g): NR 3 (exposed time: 9–21 min) sessions/week
×4 weeks
Physical function
WOMAC, CST, BBS
Pain VAS
G1 vs G2,
Sign increase in VAS and WOMAC
Moura-F et al. (Brazil) (21) 2020 Patients diagnosed with KOA
23 (NR)
G1 (15): WBV G2 (8): Sham WBV 65 (8) f (Hz): 5–14 D (mm): 2.5–7.5 a (g): 0.12–2.95 2 (exposed time: 18 min) sessions/week
×5 weeks
Quality of life
WHOQOL
WBV did not contribute to alter the quality of life of participants
Moura et al. (Brazil) (22) 2020 Obese patients diagnosed with KOA
37 (7/30)
G1 (19): WBV
62.32 (2.52) G2 (18): Sham WBV
68.06 (2.02)
f (Hz): 5 D (mm): 2.5–7.5 a (g): 0.12–0.37 3 bouts, 1 session, total 11 min Pain VAS
Physical function TUG, ATF, Borg scale
G1 vs G2,
sign increase in VAS, TUG and ATF
Simão et al
(Brazil) (16) 2019
Female patients diagnosed with KOA
15 (0/15)
G1 (7): WBV+ST G1: 75 (6.5) G2 (8): ST
G2: 71 (3.3)
f (Hz):35,40 A (mm): 4 a (g): 2.78–3.26 3 (exposed time: 6–16 min) sessions/week
×12 weeks
Knee strength
IQMS
G1 vs G2,
sign increase in IQMS
Lai et al. (China) (15) 2019 Patients diagnosed with KOA
41 (5/36)
G1 (20): WBV+ST 64.1 (4.95)
G2 (21): ST
65 (4.39)
f (Hz): 20 A (mm): 2 a (g): NR 3 (exposed time: 18–58.5 min) sessions/week
×8 weeks
Physical function TUG, 6MWT
Knee strength ISK
G1 vs G2,
sign increase in knee extensor ISK
Bokaeian et al. (Iran) (29) 2016 Patients diagnosed with KOA and able to walk
26 (2/24)
G1 (15): WBV+SE 51.8 (8.3)
G2 (11): SE
54.0 (3.9)
f (Hz): 25–30 A (mm): 2 a (g): NR 3 (exposed time: 9–31.5 min) sessions/week
×8 weeks
Knee strength ISK
Pain VAS Physical function WOMAC, 2MWT, TUG, 50FWT
G1 vs G2,
sign increase in knee extensor ISK, 2MWT, TUG and 50FWT
Wang P et al. (China) (24) 2016 Patients diagnosed with KOA based on criteria of ACR
39 (16/23)
G1 (19): WBV+QSE 61.1 (7.1)
G2 (20): QSE
61.5 (7.3)
f (Hz): 35 A (mm): 4–6 a (g): 1.0 5 (exposed time: 75 min) sessions/week
×12 weeks
Physical function TUG, 6MWT, WOMAC, gait analysis
Pain VAS
G1 vs G2,
sign increase in VAS, WOMAC, 6MWT, TUG and gait speed
Wang et al
(China) (14) 2016
Patients diagnosed with KOA based on criteria of ACR
99 (28/71)
G1 (49): WBV+QSE 61.2 (9.6)
G2 (50): QSE
61.5 (9.1)
f (Hz): 35 A (mm): 4–6 a (g): 1.0 5 (exposed time: 75 min) sessions/week
×24 weeks
Quality of life SF-36 Pain VAS Physical function TUG, 6MWT, WOMAC Knee strength ISM G1 vs G2, sign increase in VAS, SF-36, TUG, 6MWT, WOMAC and knee extensor ISM
Tsuji et al
(Japan) (27) 2014
Postmenopausal women diagnosed with KOA
38 (0/38)
G1 (29): WBV+HBE
62.1 (5.5)
G2 (9): HBE
60.9 (4.6)
f (Hz): 30,40 A (mm): 2.5 a (g): NR 3 (exposed time: 54–69 min) sessions/week
×8 weeks
Knee strength ISM, ISK
Pain VAS
Physical function JKOM, TUG
G1 vs G2,
sign increase in JKOM and TUG
Park et al
(Korea) (26) 2013
Women diagnosed with KOA
22 (0/22)
G1 (11): WBV+HBE
62.5 (5.66)
G2 (11): HBE
60.0 (6.22)
f (Hz): 12,14 A (mm): 2.5–5 a (g): NR 3 (exposed time: 60 min) sessions/week
×8 weeks
Knee strength ISK, ISM
Physical function KWOMAC, LSS, SBCS Pain NRS
G1 vs G2,
sign increase in NRS
Simão et al
(Brazil) (20) 2012
Patients diagnosed with KOA
35 (4/31)
G1 (12): WBV+ST 75 (7.4)
G2 (11): ST
69 (3.7)
G3 (12): None
71 (5.3)
f (Hz): 35,40 A (mm): 4 a (g): 2–2.61 3 (exposure time: 6–16 min) sessions/week
×12 weeks
Physical function WOMAC, BBS, GST, and 6MWT G1 vs G2,
sign increase in WOMAC, BBS, and gait speed
Avelar et al
(Brazil) (19) 2011
Patients diagnosed with KOA
21 (3/18)
G1 (11): WBV+ST 75 (5)
G2 (10): ST
71 (4)
f (Hz): 35,40 A (mm): 4 a (g): 2.78–3.26 3 (exposed time: 6–16 min) sessions/week
×12 weeks
Physical function
BBS, TUG, CST,
6MWT, WOMAC
G1 vs G2,
failed to result in any significant improvement
Trans et al.
(Denmark) (28) 2009
Women diagnosed with KOA
52 (0/52)
G1 (18): WBV (BB) 58.7 (11)
G2 (17): WBV (SP)
61.5 (9.2)
G3 (17): None
61.1 (8.5)
f (Hz): 25,30 A (mm): NR a (g): NR 2 (exposure time 6–21 min) sessions/week ×8 weeks Knee strength ISK, ISM
Physical function WOMAC, TDPM
G1 vs G3,
sign increase in ISK and ISM; G2 vs G3, sign increase in
TDPM

A: amplitude; a, acceleration; ACR: American College of Rheumatology; ATF: anterior trunk flexion; BB: balance board; BBS: Berg Balance Scale; CG: control group; CST: chair stand test; D: displacement; F: female; f: frequency; G: group; GST: gait speed test; HE: health education; IQMS: isometric quadriceps muscle strength; ISM: isometric muscle strength; ISK: isokinetic muscle strength; JKOM: Japanese Knee Osteoarthritis Measure; KOA: knee osteoarthritis; KWOMAC: Korean Western Ontario McMaster score; LI: Lequesne index; LSS: Lysholm scoring scale; M: male; NR: not reported; NRS: numerical rating scale; QSE: quadriceps strengthening exercise; SBCS: Standing Balance Control Scores; SE: strengthening exercise; SF-36: Medical Outcomes Short Form 36; SP: stable platform; ST: squat training; TDPM: threshold for detective of passive movement; TUG: Timed Up and Go test; VAS: visual analogue scale; WBV: whole-body vibration; WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index; WHOQOL: World Health Organization Quality-of-Life Scale; 2/6MWT: 2/6-minute walk test; 50FWT: 50-foot walk test.